Blockchain Registration Transaction Record

Annovis Bio (NYSE: ANVS) Reports Encouraging Results for Lead Compound in Q2

Annovis Bio (NYSE: ANVS) reports positive Q2 results for lead compound, showing promise for neurodegenerative disease treatment.

Annovis Bio (NYSE: ANVS) Reports Encouraging Results for Lead Compound in Q2

This news matters because it shows promising developments in the treatment of neurodegenerative diseases, offering hope for patients and their families.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0xacf6a260a32fc6406d0efb94e51f0cd242b7d182a56afaeee5b3a46163c4e8f0
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintloftbIss-59ce1dddbecce2aa3fdadce04f3f5929